WHAT WE DO
We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies.
We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.
Synthetic biology meets directed evolution
We use synthetic antibody as a versatile and performant technology platform, that we combine with in silico and in vitro cutting edge technologies.